S&P Global [SPGI] vs CME [CME] Detailed Stock Comparison

S&P Global Inc.

NYSE
Loading...

CME Group Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: S&P Global Inc. wins in 10 metrics, CME Group Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric S&P Global Inc. CME Group Inc. Better
P/E Ratio (TTM) 29.75 24.34 CME Group Inc.
Price-to-Book Ratio 4.19 3.57 CME Group Inc.
Debt-to-Equity Ratio 37.91 12.86 CME Group Inc.
PEG Ratio 0.93 1.03 S&P Global Inc.
EV/EBITDA 19.29 21.55 S&P Global Inc.
Profit Margin (TTM) 29.15% 63.31% CME Group Inc.
Operating Margin (TTM) 38.25% 69.66% CME Group Inc.
EBITDA Margin (TTM) 38.25% 69.66% CME Group Inc.
Return on Equity 13.09% 15.92% CME Group Inc.
Return on Assets (TTM) 6.66% 1.55% S&P Global Inc.
Free Cash Flow (TTM) $5.46B $4.19B S&P Global Inc.
Dividend Yield 0.88% 4.11% CME Group Inc.
1-Year Return -16.47% 0.01% CME Group Inc.
Price-to-Sales Ratio (TTM) 8.51 15.36 S&P Global Inc.
Enterprise Value $147.44B $103.28B S&P Global Inc.
EV/Revenue Ratio 9.61 15.31 S&P Global Inc.
Gross Profit Margin (TTM) 70.12% N/A N/A
Revenue per Share (TTM) $50 $19 S&P Global Inc.
Earnings per Share (Diluted) $14.68 $11.73 S&P Global Inc.
Beta (Stock Volatility) 1.20 0.30 CME Group Inc.
Short % of Float 1.02% 1.44% S&P Global Inc.

S&P Global Inc. vs CME Group Inc. Stock Performance Analysis

Loading Price Chart...

SPGI
CME

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
S&P Global Inc.1.23%1.67%5.19%-0.59%-15.12%-17.28%
CME Group Inc.-1.28%5.57%-10.97%-15.22%-2.24%-1.33%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
S&P Global Inc.-16.47%6.00%7.22%292.46%957.59%699.29%
CME Group Inc.0.01%46.40%27.92%186.46%384.94%196.68%

Performance & Financial Health Analysis: S&P Global Inc. vs CME Group Inc.

MetricSPGICME
Market Information
Market Cap i$130.51B$103.42B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,721,1102,489,654
90 Day Avg. Volume i1,870,2972,270,221
Last Close$424.07$266.08
52 Week Range$381.61 - $579.05$244.56 - $329.16
% from 52W High-26.76%-19.16%
All-Time High$579.05 (Aug 14, 2025)$329.16 (Mar 03, 2026)
% from All-Time High-26.76%-19.16%
Growth Metrics
Quarterly Revenue Growth0.09%0.15%
Quarterly Earnings Growth0.29%0.21%
Financial Health
Profit Margin (TTM) i0.29%0.63%
Operating Margin (TTM) i0.38%0.70%
Return on Equity (TTM) i0.13%0.16%
Debt to Equity (MRQ) i37.9112.86
Cash & Liquidity
Book Value per Share (MRQ)$104.17$80.03
Cash per Share (MRQ)$6.03$7.56
Operating Cash Flow (TTM) i$5.65B$4.54B
Levered Free Cash Flow (TTM) i$4.88B$4.11B
Dividends
Last 12-Month Dividend Yield i0.88%4.11%
Last 12-Month Dividend i$3.85$12.45

Valuation & Enterprise Metrics Analysis: S&P Global Inc. vs CME Group Inc.

MetricSPGI (Apr 26, 2026)CME (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i29.7524.34
Forward P/E i19.7822.14
PEG Ratio i0.931.03
Price to Sales (TTM) i8.5115.36
Price to Book (MRQ) i4.193.57
Market Capitalization
Market Capitalization i$130.51B$103.42B
Enterprise Value i$147.44B$103.28B
Enterprise Value Metrics
Enterprise to Revenue i9.6115.31
Enterprise to EBITDA i19.2921.55
Risk & Other Metrics
Beta i1.200.30
Book Value per Share (MRQ) i$104.17$80.03

Financial Statements Comparison: S&P Global Inc. vs CME Group Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSPGI (2025)CME (2025)
Revenue/Sales i15.34B6.52B
Cost of Goods Sold i4.56B907.00M
COGS % of Revenue i29.8%13.9%
Gross Profit i10.77B5.61B
Gross Margin i70.2%86.1%
Research & Development iN/AN/A
Operating Income (EBIT) i6.18B4.23B
Operating Margin i40.3%64.9%
EBITDA i7.41B98.30M
EBITDA Margin i48.3%1.5%
Pre-Tax Income i6.23B5.33B
Pre-Tax Income % of Revenue i40.6%81.7%
Income Tax i1.41B1.26B
Income Tax % of Revenue i9.2%19.3%
Net Income (Profit) i4.82B4.07B
Profit Margin i31.4%62.5%

Balance Sheet & Liquidity Metrics

MetricSPGI (2025)CME (2025)
Cash & Equivalents i1.75B4.42B
Total Current Assets i6.30B165.36B
Total Current Assets % of Revenue i41.1%2,536.0%
Total Current Liabilities i7.64B160.30B
Total Current Liabilities % of Revenue i49.8%2,458.3%
Long-Term Debt i12.86B3.42B
Long-Term Debt % of Revenue i83.9%52.5%
Total Shareholders Equity i36.15B28.73B
Retained Earnings i23.67B6.43B
Retained Earnings % of Revenue i154.3%98.7%
Property, Plant & Equipment i857.00M0

Cash Flow Statement Comparison

MetricSPGI (2025)CME (2025)
Operating Cash Flow i5.75B4.54B
Operating Cash Flow % of Revenue i37.5%69.6%
Capital Expenditures iN/A-83.50M
Free Cash Flow i5.46B4.19B
FCF Margin i35.6%64.3%
Debt Repayment i-4.00M-750.00M
Common Stock Repurchase i-5.00B-266.10M

Short Interest & Institutional Ownership Analysis

MetricSPGICME
Shares Short i3.03M4.70M
Short Ratio i1.532.28
Short % of Float i1.02%1.44%
Shares Outstanding i298.80M362.80M
Float Shares i298.09M357.72M
% Held by Insiders i0.33%0.48%
% Held by Institutions i89.24%91.89%
% Held by Public i10.43%7.63%

Dividend Analysis & Yield Comparison: S&P Global Inc. vs CME Group Inc.

MetricSPGICME
Last 12-Month Dividend i$3.85$12.45
Last 12-Month Dividend Yield i0.88%4.11%
3-Year Avg Annual Dividend i$3.72$10.83
3-Year Avg Dividend Yield i0.20%0.92%
3-Year Total Dividends i$11.15$32.50
Ex-Dividend DateFeb 25, 2026Mar 10, 2026